Skip to main content
Pregnancy RelatedPregnancySupplementsNutrition and dietDietary supplement

What this study is

Myoinositol is an insulin-like compound that is present in both plant and animal cells. Humans synthesize it naturally, but it is also obtained in our diet. It works through an intracellular signaling pathway to increase insulin sensitivity. Myoinositol has been used as an over-the-counter (OTC) supplement in the management of polycystic ovarian syndrome due to this effect. Myoinositol has also been shown to improve glycemic profiles in pregnant euglycemic women and well as improve insulin sensitivity in pregnant patients with gestational diabetes mellitus (GDM).

This is a double blind RCT offering myo-inositol or placebo to those who are eligible and enrolled.

What's being tested

  • Myo-inositol

    Intervention · DIETARY SUPPLEMENT

    Patients would begin taking myoinositol upon recruitment

  • Myo-inositol placebo

    Intervention · DIETARY SUPPLEMENT

    Patients would begin taking placebo upon recruitment

Study details

Official title
Continuous Glucose Monitoring in Myo-inositol Supplemented Obese Pregnant Individuals: a Feasibility Pilot Randomized Control Trial
Sponsor
Tufts Medical Center
Conditions
Pregnancy Related
Enrolling
40 people
Starts
2025-03-01
Est. completion
2027-06-30
Design
Triple-blind, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗